CNSP CNS Pharmaceuticals, Inc.
Nasdaq · SEC CIK 1729427 · EDGAR
- Bought, last 12 months
- $44.0K 2 purchases by 2 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 66 since 2021-07-16, latest 2026-08-18 09:01
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Charles Faith L. | Dir | $34.0K | — |
| Fisher Michal | Dir | $10.0K | — |
| Levin Rami | CEO, Pres | — | — |
Transactions 24
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 09:01 | 2026-05-18 | CNSP | Fisher Michal | Dir | P - Purchase | $5.00 | +2,000 | 2,000 | New | +$10.0K | |
| D | 2026-08-18 09:00 | 2026-08-14 | CNSP | Levin Rami | CEO, Pres | M - OptEx | $0.00 | -4,750 | 4,750 | -50% | $0 |
| 2026-05-20 09:03 | 2026-05-18 | CNSP | Charles Faith L. | Dir | P - Purchase | $4.79 | +7,100 | 7,100 | New | +$34.0K | |
| D | 2024-02-06 | 2024-02-01 | CNSP | Climaco John M | CEO, Dir | P - Purchase | $0.3 | +166.7K | 215.7K | +340% | +$50.0K |
| D | 2024-02-06 | 2024-02-01 | CNSP | Gumulka Jerzy | Dir | P - Purchase | $0.3 | +33.3K | 43.0K | +345% | +$10,000 |
| D | 2024-02-06 | 2024-02-01 | CNSP | Downs Christopher | CFO | P - Purchase | $0.3 | +66.7K | 103.4K | +181% | +$20.0K |
| D | 2024-02-06 | 2024-02-01 | CNSP | Evans Carl Anthony | Dir | P - Purchase | $0.3 | +33.3K | 33.5K | +26,666% | +$10,000 |
| 2023-08-23 | 2023-08-22 | CNSP | Downs Christopher | CFO | P - Purchase | $1.27 | +27.0K | 36.8K | +276% | +$34.3K | |
| 2023-08-16 | 2023-08-16 | CNSP | Climaco John M | CEO, Dir | P - Purchase | $1.80 | +2,750 | 49.0K | +6% | +$4,950 | |
| MTI | 2023-08-01 | 2022-12-06+ | CNSP | Priebe Waldemar | 10% | S - Sale | $1.41 | -94.3K | 166.8K | -36% | -$133.1K |
| D | 2023-05-01 | 2023-04-28 | CNSP | Climaco John M | CEO, Dir | M - OptEx | — | +1,250 | 46.3K | +3% | — |
| D | 2023-05-01 | 2023-04-28 | CNSP | Downs Christopher | CFO | M - OptEx | — | +521 | 9,772 | +6% | — |
| 2023-04-21 | 2023-04-19 | CNSP | Gumulka Jerzy | Dir | P - Purchase | $1.70 | +2,500 | 9,673 | +35% | +$4,250 | |
| 2023-04-18 | 2023-04-17 | CNSP | Downs Christopher | CFO | P - Purchase | $3.20 | +3,100 | 9,251 | +50% | +$9,920 | |
| 2023-04-17 | 2023-04-10 | CNSP | Gumulka Jerzy | Dir | P - Purchase | $0.74 | +7,173 | 7,173 | New | +$5,308 | |
| 2023-04-14 | 2023-04-12 | CNSP | Climaco John M | CEO, Dir | P - Purchase | $0.69 | +15.0K | 45.0K | +50% | +$10.3K | |
| 2022-03-14 | 2022-03-11 | CNSP | Downs Christopher | CFO | A - Grant | $0.31 | +33.0K | 184.5K | +22% | +$10.2K | |
| 2022-03-09 | 2022-03-07 | CNSP | Keyes Jeffry R. | Dir | A - Grant | $0.3 | +11.1K | 11.1K | New | +$3,330 | |
| 2022-03-09 | 2022-03-08 | CNSP | Evans Carl Anthony | Dir | A - Grant | $0.27 | +3,750 | 3,750 | New | +$1,013 | |
| 2022-03-08 | 2022-03-07 | CNSP | Climaco John M | CEO, Dir | A - Grant | $0.28 | +35.0K | 940.3K | +4% | +$9,800 | |
| I | 2022-01-25 | 2020-05-05 | CNSP | Priebe Waldemar | 10% | J - Other | — | -1.50M | 7.53M | -17% | — |
| 2021-12-07 | 2021-12-06 | CNSP | Downs Christopher | CFO | P - Purchase | $0.94 | +5,000 | 151.5K | +3% | +$4,700 | |
| 2021-11-22 | 2021-11-19 | CNSP | Downs Christopher | CFO | P - Purchase | $1.15 | +4,500 | 146.5K | +3% | +$5,175 | |
| 2021-11-18 | 2021-11-16 | CNSP | Climaco John M | CEO, Dir | A - Grant | $1.28 | +5,000 | 905.3K | +0.6% | +$6,400 |
Purchase Sale Sale after option exercise All abbreviations